LOGIN  |  REGISTER
Viking Therapeutics

Recent Insider Transactions - iTeos Therapeutics (NASDAQ: ITOS)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ITOS iTeos Therapeutics
Gall Matthew / officer: Chief Financial Officer
11/19/2024
Buy
$7.73
5,000
$39K
65,429